Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2009;54:345-351
Published online before print June 29, 2009, doi: 10.1161/HYPERTENSIONAHA.109.132191
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
54/2/345    most recent
HYPERTENSIONAHA.109.132191v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Walsh, S. K.
Right arrow Articles by Kenny, L. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walsh, S. K.
Right arrow Articles by Kenny, L. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Risk Pregnancy
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow Animal models of human disease
Right arrow Other hypertension
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2009;54:345.)
© 2009 American Heart Association, Inc.


Original Articles

Plasma-Mediated Vascular Dysfunction in the Reduced Uterine Perfusion Pressure Model of Preeclampsia

A Microvascular Characterization

Sarah K. Walsh; Fred A. English; Edward J. Johns; Louise C. Kenny

From the Anu Research Centre, Department of Obstetrics and Gynaecology (S.K.W., F.A.E., L.C.K.), University College Cork, Cork University Maternity Hospital and the Department of Physiology (E.J.J.), University College Cork, Ireland.

Correspondence to Dr Sarah K. Walsh, PhD, Anu Research Centre, Department of Obstetrics and Gynaecology, University College Cork, Cork University Maternity Hospital, Wilton, Cork, Ireland. E-mail S.Walsh{at}ucc.ie

Preeclampsia is associated with widespread maternal vascular dysfunction, which is thought to be mediated by circulating factor(s). The aim of the study was to characterize vascular function in the reduced uterine perfusion pressure (RUPP) rat model of preeclampsia and to investigate the role of plasma factors in mediating any observed changes in vascular reactivity. Mean arterial blood pressure and vascular function were measured in RUPP and control rats. Mesenteric vessels from both virgin and pregnant rats were exposed for 1 hour or overnight to plasma from both RUPP and control rats and their vascular function assessed. RUPP rats were characterized by severe hypertension, restricted fetal growth, and reduced placental weight (P<0.001). Vasorelaxation was impaired in resistance vessels from RUPP compared with control rats (acetylcholine: Rmax 70±3 versus 92±1 [NP] and 93±3% [sham], P<0.01; bradykinin: 40±2 versus 62±2 [NP] and 59±4% [sham], P<0.001). Incubation of vessels from pregnant (but not virgin) animals with RUPP plasma overnight resulted in an attenuation of vasorelaxant responses (acetylcholine: 63±7 versus 86±2%, P<0.05; bradykinin: 35±5 versus 55±6%, P<0.001). The residual relaxant response in RUPP plasma-treated vessels was not further attenuated after treatment with N{omega}-nitro-L-arginine methyl ester (acetylcholine: 57±7 versus 63±7%, ns; bradykinin: 37±5 versus 35±5%, ns). The RUPP rat model is characterized by an impaired response to vasodilators which may be attributable to one or more circulating factors. This plasma-mediated endothelial dysfunction appears to be a pregnancy-dependent effect. Furthermore, nitric oxide–mediated vasorelaxation appears to be absent in RUPP plasma-treated vessels.


Key Words: preeclampsia • reduced uterine perfusion pressure • endothelium • hypertension • plasma • nitric oxide